Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...
Reexamination Certificate
2007-05-29
2007-05-29
Campell, Bruce R. (Department: 1648)
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
C435S236000, C435S239000, C424S199100, C424S204100, C424S211100, C424S224100
Reexamination Certificate
active
10268197
ABSTRACT:
Live rabies virus vaccines comprising a recombinant rabies virus genome which overexpresses the rabies virus G protein increase apoptotic activity in infected cells, and enhance the generation of anti-rabies immunity in a subject.
REFERENCES:
patent: 5853735 (1998-12-01), Benejean et al.
patent: WO 01/70932 (2001-09-01), None
patent: WO01/70932 (2001-09-01), None
Morimoto et al. J of Neurovirology 2000, vol. 6, pp. 373-381.
Conzelmann Annual Rev Genetics 1998, from IDS.
Dietzschold et al. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus, PNAS 1983, vol. 80. pp. 70-74.
Morimoto, K et al., Genetic engineering of live rabies vaccines, Vaccine, vol. 19, Issues 25-26, May 14, 2001, pp. 3543-3551.
Dietzschold et al. New appraoches to the prevention and eradiction of rabies, Expert Rev. Vaccines 2003, vol. 2 (3). pp. 399-406.
Chattergoon Ma et al. (2000),Nat. Biotech. 18: 974-979.
Conzelman K-K (1998),Ann. Rev. Genet. 32: 123-62.
Dietzschold B et al. (1985),J. Virol. 56: 12-18.
Galelli A et al. (2000),J. NeuroVirol. 6: 359-372.
Kothakota S et al. (1997),Science278: 294-297.
Morimoto K et al. (2000),J. NeuroVirol. 6: 373-381.
Morimoto K et al. (1999),J. Virol. 73: 510-517.
Pulmanausahakul R et al. (2001),J. Virol. 75(22): 10800-10807.
Restifo NP (2000),Curr. Opin. Immunol. 12: 597-603.
Rovere P et al. (1998),J. Immunol. 161: 4467-4471.
Sasaki S et al. (2001),Nat. Biotech. 19: 543-547.
Shi Y et al. (2000),P.N.A.S. USA97: 14590-14595.
Virag L. et al. (1998),Immunol. 94: 345-355.
Wiktor TJ (1977),P.N.A.S. USA74: 334-338.
Yan X et al. (2001),J. Neurovirol. 7: 518-527.
Faber M et al. (2002),Journal of Virology, 76: 3374-3381.
Jallet C, et al. (1999),Journal of Virology, 73: 225-233.
Finke S, et al. (2000),Journal of Virology, 74: 7261-7269.
Morimoto, K et al. (2001),Vaccine19, 3543-3551.
Dietzschold Bernhard
Hooper D. Craig
Schnell Matthias J.
Campell Bruce R.
Drinker Biddle & Reath LLP
Hill Myron G.
Monaco Daniel A.
Thomas Jefferson University
LandOfFree
Recombinant rabies vaccine and methods of preparation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant rabies vaccine and methods of preparation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant rabies vaccine and methods of preparation and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3773930